Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

FRONTIERS IN PHARMACOLOGY(2018)

引用 1|浏览5
暂无评分
关键词
bimagrumab,ActRIIA/B receptors,skeletal muscle,anabolic steroids,myostatin/activin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要